Lupin's Amifampridine Tablets approved by US FDA

Roche wins FDA clearance for customisable respiratory pathogen test

INOVIO's VOCERYQ receives US FDA accelerated approval to reduce surgery frequency in adults with RRP

Immunome secures EMA validation of varegacestat application for desmoid tumors

FDA approves Sun Pharma's ILUMYA for psoriatic arthritis

AFT Pharmaceuticals' COMBOGESIC pain medication available to US healthcare organisations through Mark Cuban Cost Plus Marketplace

Celularity and Vesalius sign exclusive US peptide manufacturing agreement

Daiichi Sankyo secures EMA validation for two triple-combination cholesterol therapies

TME Pharma signs exclusive negotiation agreement with Japan's TMS for NOX-A12 rights

United Therapeutics receives FDA clearance to advance inhaled PAH therapy into clinical trials

US WorldMeds acquires Orbus Therapeutics

Enhertu wins EU approval for HER2-positive early breast cancer treatment

Citius Oncology reports growth in LYMPHIR unit shipments to US wholesalers

Cumberland Pharmaceuticals to submit New Drug Application for ifetroban

Labcorp, Charles River and FDA collaborate on advancing preclinical methods for evaluating drug abuse potential